2m 2m 2m 2m 2m 2m 2m
APREA THERAPEUT (APRE)
NASDAQ
$0.72-$0.008 (-1.04%)
Price as of Oct 02, 2026 6:24 PM EDT- $9.1MMarket Cap
- -51.11%1-Year Change
- BiotechnologyIndustry
APREA THERAPEUT (APRE)
$0.72-$0.008 (-1.04%)
APRE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.72 | ||
Change | -$0.03 (-3.53%) | ||
Open | $0.76 | ||
High | $0.78 | ||
Low | $0.68 | ||
Previous Close | $0.75 | ||
Volume | 779,689 | ||
30-Day Average Volume | 221,255 | ||
1-Week Change | -7.21% | ||
1-Month Change | -13.43% | ||
1-Year Change | -51.11% | ||
3-Year Change | -82.64% | ||
5-Year Change | -99.27% | ||
Fundamentals | |||
Shares Outstanding | 12.6M | ||
Total Assets | $42.3M | ||
Market Cap | $9.1M | ||
Enterprise Value | -$32.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.6M | ||
Free Cash Flow | -$3.3M | ||
EBIT | -$3.6M | ||
EBITDA | -$3.6M | ||
Net Working Capital | $38.8M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | 9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 02/13/2023 | ||
Earnings & Revenue